A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Chemico-Biological Interactions

• Publication date

  1997-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-2797(97)00047-1PMID 9291997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.

  1996cited by this paper
• Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives

  1995cited by this paper
• Phenserine and ring C hetero‐analogues: Drug candidates for the treatment of Alzheimer's disease

  1995cited by this paper
• Exploring QSAR.

  1995cited by this paper
• Flexible 1-[(2-aminoethoxy)alkyl]-3-ar(o)yl(thio)ureas as novel acetylcholinesterase inhibitors. Synthesis and biochemical evaluation.

  1995cited by this paper
• Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease.

  1995cited by this paper
• The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis.

  1995cited by this paper
• Comparative Quantitative Structure—Activity Relationship: Insect Versus Vertebrate Cholinesterase

  1995cited by this paper
• Novel [2-(4-piperidinyl)ethyl](thio)ureas: synthesis and antiacetylcholinesterase activity.

  1994cited by this paper
• Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies

  1994cited by this paper
• Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase.

  1994cited by this paper
• Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program

  1994cited by this paper
• Phenylcarbamates of (-)-Eseroline, (-)-N1-Noreseroline and (-)- Physovenol: Selective Inhibitors of Acetyl and/or Butyrylcholinesterase.

  1993cited by this paper
• Quantitative structure-activity relationships and the unnamed science

  1993cited by this paper
• Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs.

  1993cited by this paper
• Chapter 21. Alzheimer's Disease: Current Therapeutic Approaches

  1993cited by this paper
• Syntheses, resolution, and structure-activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues.

  1992cited by this paper
• Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.

  1992cited by this paper
• Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.

  1992cited by this paper
• QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.

  1992cited by this paper
• Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase

  1992cited by this paper
• Central Cholinergic Agents. I. Potent Acetylcholinesterase Inhibitors, 2-[ω-[N-Alkyl-N-(ω-phenyl-alkyl)amino]alkyl]-1H-isoindole-1,3(2H)-diones, Based on a New Hypothesis of the Enzyme's Active Site

  1991cited by this paper
• Central cholinergic agents. I. Potent acetylcholinesterase inhibitors, 2-[omega-[N-alkyl-N-(omega-phenyl-alkyl)amino]alkyl]-1H-isoindole- 1,3(2H)-diones, based on a new hypothesis of the enzyme's active site.

  1991cited by this paper
• Central cholinergic agents. II. Synthesis and acetylcholinesterase inhibitory activities of N-[omega-[N-alkyl-N-(phenylmethyl)amino]alkyl]-3-arylpropenamides.

  1991cited by this paper
• Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein

  1991cited by this paper
• Comprehensive medicinal chemistry

  1991cited by this paper
• Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives.

  1991cited by this paper
• Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives.

  1990cited by this paper
• 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.

  1989cited by this paper
• Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine.

  1988cited by this paper
• Computer-aided molecular design.

  1987cited by this paper
• QSAR studies on enzyme inhibitors

  1987cited by this paper
• Quantitative structure-activity relationships and molecular graphics in ligand receptor interactions: amidine inhibition of trypsin.

  1986cited by this paper
• 10 - Chemicals Affecting Insects and Mites

  1983cited by this paper
• Quantitative structure-activity relationships of drugs

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Substituent constants for correlation analysis in chemistry and biology

  1979cited by this paper
• A hydrophobic binding site in acetylcholinesterase.

  1975cited by this paper
• Pesticidal Activity and Structure, Structure and Insecticidal Activity of Some Diethyl Substituted Phenyl Phosphates

  1956cited by this paper

• Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer’s disease

  2021cites this paper
• ABCpred: a webserver for the discovery of acetyl- and butyryl-cholinesterase inhibitors

  2021cites this paper
• Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease

  2021cites this paper
• 4D-QSAR Molecular Modeling and Analysis of Flavonoid Derivatives as Acetylcholinesterase Inhibitors.

  2021cites this paper
• Evaluation of Amaryllidaceae alkaloids as inhibitors of human acetylcholinesterase by QSAR analysis and molecular docking

  2021cites this paper
• Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.

  2019cites this paper
• Multi-Target Drug Design Using Chem-Bioinformatic Approaches

  2019influential citation
• Computer aided drug design using virtual screening and molecular energy calculation of a specific neurodegenerative diseases

  2018cites this paper
• Computational Design of Multitarget Drugs Against Alzheimer’s Disease

  2018cites this paper
• Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.

  2017cites this paper
• QSAR Models towards Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease

  2017cites this paper
• In Silico Studies in Drug Research Against Neurodegenerative Diseases

  2017cites this paper
• Design and synthesis of new piperidone grafted acetylcholinesterase inhibitors.

  2017cites this paper
• Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.

  2015cites this paper
• 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment

  2015cites this paper
• Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

  2014cites this paper
• Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesterase

  2014cites this paper
• QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.

  2014cites this paper
• QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP STUDY FOR THE PREDICTION OF INHIBITORY CONCENTRATION 50 FOR 5-N-ACETYL-BETA-D-NEURAMINIC ACID STRUCTURALLY SIMILAR COMPOUNDS USING NEURAL NET

  2014cites this paper
• Biological Evaluation of Halogenated Thioureas as Cholinesterases Inhibitors Against Alzheimer’s Disease & Molecular Modeling Studies

  2014cites this paper
• Molecular Docking Studies and in-vitro Acetylcholinesterase Inhibition by Terpenoids and Flavonoids

  2013cites this paper
• Discovery of anti-Alzheimer agents: current ligand-based approaches toward the design of acetylcholinesterase inhibitors.

  2012cites this paper
• Molecular Docking Guided Comparative GFA, G/PLS, SVM and ANN Models of Structurally Diverse Dual Binding Site Acetylcholinesterase Inhibitors

  2011cites this paper
• QSAR study for the prediction of Half Maximal Inhibitory Concentration of Compounds structurally similar to Glycerol (Gliserole Yapisal Olarak Benzeyen Bileşiklerin Yari Maksimal İnhibisyon Konsantrasyonlarinin QSAR Çalişmasi İle Tahmini)

  2010cites this paper
• Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.

  2010cites this paper
• In-silico analysis and QSAR studies of tacrine hybrids with ubiquitin ligase on Alzheimer's disease

  2010cites this paper
• Shape Analysis in Bioinformatics

  2009cites this paper
• QSAR Studies on N-aryl Derivative Activity Towards Alzheimer’s Disease

  2009cites this paper
• Modeling of acetylcholinesterase inhibition by tacrine analogues using Bayesian-regularized Genetic Neural Networks and ensemble averaging

  2006cites this paper
• Dimeric and hybrid anti-Alzheimer drug candidates.

  2006cites this paper
• Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study.

  2005cites this paper
• Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase.

  2003cites this paper
• In Silico Application of Quantum Chemical Methods for Relating Toxicity to Chemical Reactivity

  2003cites this paper
• Hypochlorous acid is a potent inhibitor of acetylcholinesterase.

  2002cites this paper
• Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.

  2001cites this paper
• Prediction of organophosphorus acetylcholinesterase inhibition using three-dimensional quantitative structure-activity relationship (3D-QSAR) methods.

  2001cites this paper
• Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms.

  2001cites this paper
• SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.

  2000cites this paper
• Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives.

  2000cites this paper
• Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.

  2000cites this paper
• The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.

  1998cites this paper
• Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.

  1998cites this paper